Medindia

X

Edwards Sapien 3 Prosthetic Aortic Heart Valve Gets FDA Approval In U.S, Europe

by Julia Samuel on  June 19, 2015 at 6:04 PM Medical Gadgets   - G J E 4
Edwards has announced the release of its latest transcatheter aortic heart valve, the SAPIEN 3, including the Commander Delivery System, to the U.S. market as the FDA has issued approval.
Edwards Sapien 3 Prosthetic Aortic Heart Valve Gets FDA Approval In U.S, Europe
Edwards Sapien 3 Prosthetic Aortic Heart Valve Gets FDA Approval In U.S, Europe
Advertisement

The device was designed to lower the chances of leakage around the valve, which should reduce various side effects, including the potential for stroke.

Advertisement
The SAPIEN 3 now has an outer layer of polyethylene terephthalate over the frame of the device that more consistently plugs blood flow from having a chance to pass through outside of the valve.

The SAPIEN 3 valve is the only commercial transcatheter heart valve, which has shown a low rate of complication. The valve can be implanted through multiple approaches: transfemoral, transapical or transaortic.

"Edwards SAPIEN 3 valve has a unique design intended to provide a simpler procedure, along with fewer post-procedural complications and a faster recovery for patients," said Larry L. Wood, Edwards' corporate vice president, transcatheter heart valves.

"Based on our clinical leadership in transcatheter heart valves, we believe the SAPIEN 3 valve's characteristics and procedural refinements have the potential to transform TAVI for both physicians and patients."

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All